Search Results

You are looking at 161 - 170 of 2,852 items for :

  • Refine by Access: All x
Clear All
Full access

BPI20-009: Impact of Preoperative Biliary Drainage on Postoperative Outcome for Obstructive Jaundice Patients

Zhihui Gao, Shen Sheng, Liu Han, Ni Xiaoling, Suo Tao, Wang Yueqi, and Houbao Liu

Background and aim: Indications of preoperative biliary drainage (PBD) for malignant obstructive jaundice are still controversial. The present study aims to assess the impact of preoperative biliary drainage on postoperative outcome, to define the

Full access

Leveraging Surgical Case Volume in Improving Cancer Care Outcomes: Where Do We Go From Here?

Henry Soo-Min Park

Over the course of the past quarter century, an increasing number of observational studies have been published investigating how surgeon and hospital experience can influence the outcomes of patients undergoing complex surgeries. Early studies

Full access

CLO23-046: Pooled Outcomes of Anti-BRAF Agents in Advanced Stage Colorectal Cancer

Mackenzie Taychert, Ankita Aggarwal, David Tabagari, Urja Nagadia, Sai Gajagowni, Venkata Vosuri, and Kushal Naha

Introduction: BRAF mutations in advanced stage colorectal cancers are observed in 8-12% of patients and BRAF V600E is the most frequent alteration. This mutation confers poor prognosis and treatment outcomes with routine systemic chemotherapy

Full access

CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients

Nishanth Thalambedu, Phillip Farmer, Clyde Bailey, Lakshmi Yarlagadda, Samer Al-Hadidi, Sharmilan Thanendrarajan, Maurizio Zangari, Carolina Schinke, and Frits VanRhee

analyze the outcomes among IgD MM patients who underwent upfront ASCT (ASCT within 12 months of diagnosis) at our institution. Methods: We conducted a retrospective study among patients with IgD MM and underwent upfront ASCT at the University of Arkansas

Full access

A Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients’ Transportation Insecurity

Krisda H. Chaiyachati, Diana Krause, Jessica Sugalski, Evan M. Graboyes, and Lawrence N. Shulman

widened racial and income disparities in cancer treatment outcomes. 19 – 21 Although national organizations such as the National Academies of Sciences, Engineering, and Medicine have identified transportation insecurity as a key social risk factor, 22

Full access

Stereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomes

Puneeth Iyengar and Robert D. Timmerman

To understand why radiation oncologists moved toward the use of SABR in treating primary NSCLCs and metastatic disease to the lungs, the poor outcomes in controlling these disease states with fractionated radiation therapy (eg, 25–37 daily treatments

Full access

Testicular Cancer Survivorship

Chunkit Fung, Paul C. Dinh Jr, Sophie D. Fossa, and Lois B. Travis

long-term adverse health outcomes (AHOs) among TCS is critically important for the development of risk-stratified, evidence-based follow-up guidelines. A multi-institutional study 40 among North American TCS (median age, 37 years) after cisplatin

Full access

Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLC

Cary P. Gross, Craig S. Meyer, Sarika Ogale, Matthew Kent, and William B. Wong

in survival over the past decade. 2 Advances in personalized therapies for advanced NSCLC (aNSCLC), which allow treatment based on the genetic makeup of a tumor, have significantly contributed to the improved outcomes of patients. 2 Despite the

Full access

BIO24-031: Hierarchical Multimodal Learning on Pan-Squamous Cell Carcinomas for Improved Survival Outcomes

Asim Waqas, Aakash Tripathi, Ashwin Mukund, Paul Stewart, Mia Naeini, and Ghulam Rasool

clinical outcomes. Our framework (1) generates embeddings from multi-resolution datasets, (2) learns and improves relational embeddings at various stages of data hierarchy using GNNs, (3) fuses the learned embeddings into a unified graph representation, and

Full access

HSR22-134: Outcomes of Patients who Received Radiation Therapy for Brain Metastases From Gynecologic Malignancies

Eric Chen, Todd Aquino-Michaels, Sadhvi Batra, Riley Lochner, Anthony Rizzo, Ravi Kyasaram, Eleanor Harris, Tiffany Hodges, Lindsay Ferguson, and Serah Choi

Background : Even among patients with stage IV gynecologic cancers, metastases to the brain are rare and prognosis remains poor. Given the paucity of data, this study aimed to describe the outcomes of this patient population who underwent